The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 340:1471-1475 May 13, 1999 Number 19
NextNext

Deaths Related to Liposuction
Rama B. Rao, M.D., Susan F. Ely, M.D., M.P.H.T.M., and Robert S. Hoffman, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background The technique of tumescent liposuction involves the subcutaneous infusion of a solution containing lidocaine, followed by the aspiration of fat through microcannulas. Although the recommended doses of lidocaine are as high as 55 mg per kilogram of body weight, few safety data are available. Since reporting of adverse events associated with tumescent liposuction is not mandatory, the incidence of complications and deaths is unknown.

Methods We identified 5 deaths after tumescent liposuction among 48,527 deaths referred to the Office of Chief Medical Examiner of the City of New York between 1993 and 1998. The patients' records and postmortem examination results were reviewed to identify common contributory factors.

Results The five patients had received lidocaine in doses ranging from 10 to 40 mg per kilogram. Other drugs, such as midazolam, were also administered. Three patients died as a result of precipitous intraoperative hypotension and bradycardia with no definitively identified cause. Postmortem blood lidocaine concentrations in two of the patients were 5.2 and 2 mg per liter. One patient died of fluid overload, and one died of deep venous thrombosis of calf veins with pulmonary thromboembolism after tumescent liposuction of the legs.

Conclusions Tumescent liposuction can be fatal, perhaps in part because of lidocaine toxicity or lidocaine-related drug interactions.


Source Information

From the New York City Poison Control Center, Department of Surgery–Emergency Medicine, New York University Medical Center and Bellevue Hospital Center (R.B.R., R.S.H.); and the Office of Chief Medical Examiner of the City of New York and the Department of Forensic Medicine, New York University Medical Center (S.F.E.) — all in New York.

Address reprint requests to Dr. Rao at the New York City Poison Control Center, 455 First Ave., Rm. 123, New York, NY 10016, or at raorama{at}pol.net.

Full Text of this Article


Related Letters:

Deaths Related to Liposuction
Ginsberg M. M., Gresham L., Vermeulen C., Serra M., Roujeau J.-C., Talmor M., Barie P. S., Klein J. A., Rigel D. S., Wheeland R. G., Schnur P., Penn J., Fodor P. B., Rao R. B., Ely S. F., Hoffman R. S.
Extract | Full Text  
N Engl J Med 1999; 341:1000-1003, Sep 23, 1999. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.